Formulary Search Results for: DESMOPRESSIN 7.4.2
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Restrictions:
Desmopressin oral lyophilisate for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults is restricted to specialist initiation by a consultant gynaecologist/urogynaecologist for use in patients aged 65 years and above (also see prescribing notes below).
Prescribing Notes:
- A positive diagnosis should be made following analysis of a 3-day volume chart
- Assessment of efficacy is required every 3 months
- Monitoring arrangements will be the responsibility of secondary care
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Prescribing Notes:
Pelvic floor exercises are considered the first line treatment for stress incontinence in women.
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Prescribing Notes:
Oxybutynin should be used with caution in older patients following evidence of potential cognitive impairment. When prescribing antimuscarinics, consideration should be given to other factors which may influence the patient’s condition and response to treatment (e.g. excessive intake of fluid and other lifestyle choices).
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Prescribing Notes:
Oxybutynin should be used with caution in older patients following evidence of potential cognitive impairment. When prescribing antimuscarinics, consideration should be given to other factors which may influence the patient’s condition and response to treatment (e.g. excessive intake of fluid and other lifestyle choices).
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Prescribing Notes:
Oxybutynin should be used with caution in older patients following evidence of potential cognitive impairment. Other oxybutynin preparations are included in the Total Formulary. When prescribing antimuscarinics, consideration should be given to other factors which may influence the patient’s condition and response to treatment (e.g. excessive intake of fluid and other lifestyle choices).
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Restrictions:
Use for the management of bladder dysfunction (overactive bladder with symptoms of urinary incontinence, urgency and frequency) is restricted to specialist use in adult patients who have failed appropriate oral treatment options.
Use in the management of urinary incontinence in adult patients with neurogenic detrusor overactivity due to subcervical spinal cord injury (traumatic or non-traumatic) or multiple sclerosis, who are not adequately managed with anticholinergics is restricted to specialist use.
Prescribing Notes:
Prescribe by brand name.
6.5.2 Posterior pituitary hormones and antagonists - View Category
Restrictions:
Desmopressin tablets are restricted to use in patients unable to use intramuscular preparations. Intravenous desmopressin is restricted to use in specialist haemophilia centres.
Prescribing Notes:
- Used for treatment of diabetes insipidus, primary nocturnal enuresis and postoperative polyuria or polydipsia. Due to the high level of adverse reactions, desmopressin nasal spray is no longer indicated for primary nocturnal enuresis. Oral formulations should be considered as an alternative.
- For use in the symtomatic treatment of nocturia due to idiopathic nocturnal polyuria see section 7.4.2